For: | Minicucci EM, da Silva GN, Salvadori DMF. Relationship between head and neck cancer therapy and some genetic endpoints. World J Clin Oncol 2014; 5(2): 93-102 [PMID: 24829856 DOI: 10.5306/wjco.v5.i2.93] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v5/i2/93.htm |
Number | Citing Articles |
1 |
Beatrice Arezzini, Daniela Vecchio, Cinzia Signorini, Blerta Stringa, Concetta Gardi. F2-isoprostanes can mediate bleomycin-induced lung fibrosis. Free Radical Biology and Medicine 2018; 115: 1 doi: 10.1016/j.freeradbiomed.2017.11.007
|
2 |
Nagely J. Mejía-Chuquispuma, Katia V. Flores-Jiménez, Allison C. Castro-Auqui, Manuel A. Mattos-Vela. Manejo odontológico de las manifestaciones orales inducidas por radioterapia de cabeza y cuello. Bionatura 2023; 8(1): 1 doi: 10.21931/RB/2023.08.01.30
|
3 |
Víctor A. Solarte, Jaiver E. Rosas, Zuly J. Rivera, Martha L. Arango-Rodríguez, Javier E. García, Jean-Paul Vernot. A Tetrameric Peptide Derived from Bovine Lactoferricin Exhibits Specific Cytotoxic Effects against Oral Squamous-Cell Carcinoma Cell Lines. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/630179
|
4 |
Yihui Wen, Jennifer R Grandis. Emerging drugs for head and neck cancer. Expert Opinion on Emerging Drugs 2015; 20(2): 313 doi: 10.1517/14728214.2015.1031653
|
5 |
A Ivashkevich, T Ohnesorg, C E Sparbier, H Elsaleh. Advances in biological dosimetry. Journal of Physics: Conference Series 2017; 777: 012012 doi: 10.1088/1742-6596/777/1/012012
|
6 |
Natalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long, Trinayan Kashyap, Christian Argueta, Yosef Landesman, Mehlika Hazar-Rethinam, Samuel Boros, Benedict Panizza, Maarten Jacquemyn, Dirk Daelemans, Orla M. Gannon, Nicholas A. Saunders. Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas. Science Translational Medicine 2018; 10(447) doi: 10.1126/scitranslmed.aar7223
|
7 |
K.L. Adeleye, A.R. Li, Y. Xie, S. Pochampally, D. Hamilton, F. Garcia-Godoy, D.D. Miller, W. Li. Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma. Journal of Dental Research 2024; 103(9): 926 doi: 10.1177/00220345241261982
|
8 |
Wei Yang, Xiao-Ming Wang, Hong-Yan Yuan, Zhi-Hui Liu, Shuang Gao, Liang Peng. Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma. Oncology Letters 2017; 13(5): 3198 doi: 10.3892/ol.2017.5850
|
9 |
Mehlika Hazar-Rethinam, Lilia Merida de Long, Orla M. Gannon, Eleni Topkas, Samuel Boros, Ana Cristina Vargas, Marcin Dzienis, Pamela Mukhopadhyay, Fiona Simpson, Liliana Endo-Munoz, Nicholas A. Saunders. A Novel E2F/Sphingosine Kinase 1 Axis Regulates Anthracycline Response in Squamous Cell Carcinoma. Clinical Cancer Research 2015; 21(2): 417 doi: 10.1158/1078-0432.CCR-14-1962
|
10 |
Pamela de Oliveira Soares, Patrícia Maluf Cury, Rossana Verónica Mendoza López, Cláudio Roberto Cernea, Erika Erina Fukuyama, David Livingstone Alves Figueiredo, Francisco Gorgonio da Nobrega, Otavio Alberto Curioni, Fabio Daumas Nunes, Raquel Ajub Moyses, Maria Lúcia Bueno Garcia, Gautam Sethi. GTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neck. PLOS ONE 2017; 12(8): e0182600 doi: 10.1371/journal.pone.0182600
|
11 |
Edvande Xavier dos Santos Filho, Diego Antonio Costa Arantes, Angélica Ferreira Oton Leite, Aline Carvalho Batista, Elismauro Francisco de Mendonça, Ricardo Neves Marreto, Letícia Nasser Naves, Eliana Martins Lima, Marize Campos Valadares. Randomized clinical trial of a mucoadhesive formulation containing curcuminoids (Zingiberaceae) and Bidens pilosa Linn (Asteraceae) extract (FITOPROT) for prevention and treatment of oral mucositis - phase I study. Chemico-Biological Interactions 2018; 291: 228 doi: 10.1016/j.cbi.2018.06.010
|
12 |
Radosław Mlak, Tomasz Powrózek, Anna Brzozowska, Iwona Homa-Mlak, Marcin Mazurek, Teresa Małecka-Massalska. RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients. Cancer Biomarkers 2018; 22(4): 657 doi: 10.3233/CBM-171082
|